Literature DB >> 34458421

Generation of Tumour-stroma Minispheroids for Drug Efficacy Testing.

Mark Watters1, Eva Szegezdi1.   

Abstract

The three-dimensional organisation of cells in a tissue and their interaction with adjacent cells and extracellular matrix is a key determinant of cellular responses, including how tumour cells respond to stress conditions or therapeutic drugs (Elliott and Yuan, 2011). In vivo, tumour cells are embedded in a stroma formed primarily by fibroblasts that produce an extracellular matrix and enwoven with blood vessels. The 3D mixed cell type spheroid model described here incorporates these key features of the tissue microenvironment that in vivo tumours exist in; namely the three-dimensional organisation, the most abundant stromal cell types (fibroblasts and endothelial cells), and extracellular matrix. This method combined with confocal microscopy can be a powerful tool to carry out drug sensitivity, angiogenesis and cell migration/invasion assays of different tumour types.
Copyright © 2017 The Authors; exclusive licensee Bio-protocol LLC.

Entities:  

Keywords:  Breast cancer; Drug resistance; Mixed cell type 3-dimensional (3D) culture; TRAIL; Tumour sphere

Year:  2017        PMID: 34458421      PMCID: PMC8376542          DOI: 10.21769/BioProtoc.2091

Source DB:  PubMed          Journal:  Bio Protoc        ISSN: 2331-8325


  9 in total

Review 1.  A review of three-dimensional in vitro tissue models for drug discovery and transport studies.

Authors:  Nelita T Elliott; Fan Yuan
Journal:  J Pharm Sci       Date:  2010-06-08       Impact factor: 3.534

Review 2.  Life in 3D is never flat: 3D models to optimise drug delivery.

Authors:  Kathleen A Fitzgerald; Meenakshi Malhotra; Caroline M Curtin; Fergal J O' Brien; Caitriona M O' Driscoll
Journal:  J Control Release       Date:  2015-07-26       Impact factor: 9.776

3.  Anchorage-independent multi-cellular spheroids as an in vitro model of growth signaling in Ewing tumors.

Authors:  Elizabeth R Lawlor; Christina Scheel; Julia Irving; Poul H B Sorensen
Journal:  Oncogene       Date:  2002-01-10       Impact factor: 9.867

4.  Designed tumor necrosis factor-related apoptosis-inducing ligand variants initiating apoptosis exclusively via the DR5 receptor.

Authors:  Almer M van der Sloot; Vicente Tur; Eva Szegezdi; Margaret M Mullally; Robbert H Cool; Afshin Samali; Luis Serrano; Wim J Quax
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-26       Impact factor: 11.205

5.  Decoy receptors block TRAIL sensitivity at a supracellular level: the role of stromal cells in controlling tumour TRAIL sensitivity.

Authors:  L O'Leary; A M van der Sloot; C R Reis; S Deegan; A E Ryan; S P S Dhami; L S Murillo; R H Cool; P Correa de Sampaio; K Thompson; G Murphy; W J Quax; L Serrano; A Samali; E Szegezdi
Journal:  Oncogene       Date:  2015-06-08       Impact factor: 9.867

6.  A heterogeneous in vitro three dimensional model of tumour-stroma interactions regulating sprouting angiogenesis.

Authors:  Pedro Correa de Sampaio; David Auslaender; Davia Krubasik; Antonio Virgilio Failla; Jeremy N Skepper; Gillian Murphy; William R English
Journal:  PLoS One       Date:  2012-02-20       Impact factor: 3.240

7.  Multicellular tumour spheroid as a model for evaluation of [18F]FDG as biomarker for breast cancer treatment monitoring.

Authors:  Azita Monazzam; Pasha Razifar; Martin Simonsson; Fredrik Qvarnström; Raymond Josephsson; Carl Blomqvist; Bengt Långström; Mats Bergström
Journal:  Cancer Cell Int       Date:  2006-03-23       Impact factor: 5.722

8.  Multidrug resistance characterization in multicellular tumour spheroids from two human lung cancer cell lines.

Authors:  Raúl Barrera-Rodríguez; Jorge Morales Fuentes
Journal:  Cancer Cell Int       Date:  2015-04-24       Impact factor: 5.722

9.  Scaffold-Free Coculture Spheroids of Human Colonic Adenocarcinoma Cells and Normal Colonic Fibroblasts Promote Tumorigenicity in Nude Mice.

Authors:  Jong-Il Park; Jisu Lee; Ju-Lee Kwon; Hong-Bum Park; Su-Yel Lee; Ji-Yeon Kim; Jaekye Sung; Jin Man Kim; Kyu Sang Song; Kyung-Hee Kim
Journal:  Transl Oncol       Date:  2016-02       Impact factor: 4.243

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.